Urokinase-Type Plasminogen Activator Expression in Human Prostate Carcinomas
- 1 July 1996
- journal article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 312 (1), 8-11
- https://doi.org/10.1097/00000441-199607000-00002
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Urokinase plasminogen activator as a prognostic marker in different subgroups of patients with breast cancerCancer, 1994
- Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancerBreast Cancer Research and Treatment, 1993
- The plasminogen‐activation system in ovarian tumorsInternational Journal of Cancer, 1993
- Immunohistochemical Study of Tumor Cell-associated Plasminogen Activators and Plasminogen Activator Inhibitors in Lung CarcinomasChest, 1993
- The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancerGynecologic Oncology, 1992
- Involvement of Urokinase and its Receptor in the Invasiveness of Human Prostatic Carcinoma Cell LinesCancer Communications, 1991
- Increase in levels of plasminogen activator and type-1 plasminogen activator inhibitor in human breast cancer: Possible roles in tumor progression and metastasisThrombosis Research, 1991
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Plasminogen Activators in Human Prostate Cancer Cell Lines and Tumors: Correlation with the Aggressive PhenotypeJournal of Urology, 1989